HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

TFM-735

a Nrf2 inducer; structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Thiazoles: 392
      - TFM-735: 1
    - Pyrazoles: 61
      - TFM-735: 1
Organic Chemicals: 133
- Sulfur Compounds: 278
  - Thiazoles: 392
    - TFM-735: 1

Experts

1.	Furusako, Shoji: 1 article (05/2017)
2.	Hayashi, Makiko: 1 article (05/2017)
3.	Higashi, Chika: 1 article (05/2017)
4.	Kawaji, Atsuko: 1 article (05/2017)
5.	Nakamura, Masaki: 1 article (05/2017)
6.	Nakao, Kazunari: 1 article (05/2017)
7.	Saito, Ryota: 1 article (05/2017)
8.	Suzuki, Takafumi: 1 article (05/2017)
9.	Tsuda, Naoto: 1 article (05/2017)
10.	Uruno, Akira: 1 article (05/2017)

Related Diseases

1.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/05/2017 - "The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice."
2.	Disease Progression 05/05/2017 - "Therefore, these findings indicate that TFM-735 is a potent Nrf2 inducer that inhibits inflammatory cytokine production and disease progression in mice with EAE and that TFM-735 is a promising therapeutic agent for MS."

Related Drugs and Biologics

1.	Cytokines